Pharmacokinetics of High-Dose Methotrexate in Egyptian Children with Acute Lymphoblastic Leukemia: Impact of Interpatient Variations

Journal Title: IOSR Journal of Pharmacy (IOSRPHR) - Year 2015, Vol 5, Issue 10

Abstract

 Aim:Since several factors have been shown to influence the clearance of methotrexate, the purpose of this study was to identify potential relationships between patient covariates and the methotrexate clearance estimates and deduce a pharmacokinetic model for the estimation of methotrexate clearance in Egyptian pediatric ALL patients that may help dosage adjustment and achieve target steady-state plasma concentrations in a similar sittings. Patients and methods: A total of 94 pediatric patients with B-cell ALL, of whom 70 were the studied population and 24 were the test population, were treated with four courses of HDMTX doses 2.5 gm/m2 (low-risk arm) or 5 gm/m2 (standard-/high-risk arm) given every other week by intermittent intravenous infusions over 24 hours as a part of their treatment protocol. Patients were monitored for the 24 hour MTX concentration and the systemic methotrexate clearance was calculated for each methotrexate dose. Results:The studied patients had average age of 7.1 ± 4.44 years; total body weight of 30.3 ± 21.04 kg, average height of 117.63 ± 28.09 cm, body surface area of 0.97 ± 0.45 m2 and body mass index of 19.25 ± 4.49. The average creatinine clearance calculated using Schwartz formula was 167.83 ± 48.44 ml/min. The mean methotrexate clearance was 7.83 ± 4.52 L/hr. Estimated creatinine clearance and body mass index were identified as the most important factors influencing methotrexate clearance in the studied patients. Conclusion:A Pharmacokinetic model was proposed to estimate the individual methotrexate clearance for Egyptian pediatric ALL patients. The derived final regression model reasonably predicted clearance values with best fitness and precessions

Authors and Affiliations

Abdel-Hameed I. M. Ebid1,Mohamed A. M. Ibrahim1 , Sameera Ezzat2

Keywords

Related Articles

 Assessment of the Perceived Quality of Life of Non insulin Dependent Diabetic patients attending the Diabetes Clinic in Kenyatta National Hospital

BACKGROUND: Diabetes Mellitus is a common and demanding health related problem that has a wide effect on every day‟s life of the patients. It can have a profound effect on quality of life in terms of social and psycholog...

 Characterization of StyR-234 non-coding RNA in regulation of Multi-drug resistance in Salmonella enterica serovar typhi

  Non-protein coding RNAs (npcRNA) have been recently recognized in bacterial pathogens as a new group to regulate multi-drug resistance. Among several pathogenic bacterial spcecices, Salmonella enterica serovar T...

 Factors Favouring Cholelithiasis in North Indian Population

The present study was done on 132 cases those underwent cholecystectomy for benign Gall Bladder disease. Our study concluded that maximum ,58 cases(43.94%) number of cases were in the age group  of 41-50 years fol...

 Antioxidant And Cytotoxic Activities Of Crude Methanolic Extract Of Medicago Polymorpha

 Free radicals are the source of many diseases such as diabetes mellitus, cancer, arthritis, anemea, Parkinson disease, alzimer and ageing etc. Antioxidants are very important for treatment of this disease by scav...

Download PDF file
  • EP ID EP101094
  • DOI -
  • Views 103
  • Downloads 0

How To Cite

Abdel-Hameed I. M. Ebid1, Mohamed A. M. Ibrahim1, Sameera Ezzat2 (2015).  Pharmacokinetics of High-Dose Methotrexate in Egyptian Children with Acute Lymphoblastic Leukemia: Impact of Interpatient Variations. IOSR Journal of Pharmacy (IOSRPHR), 5(10), 33-42. https://europub.co.uk/articles/-A-101094